12/11/2024  17:31:45 Var. -0.86 Volume Denaro17:31:45 Lettera17:31:45 Capitalizzazione di mercato Dividend Y. Rapporto P/E
92.37CHF -0.92% 217,336
Fatturato: 20.1 mill.
-Quantità in denaro: - -Quantità in lettera: - 210.26 bill.CHF - -

Descrizione business

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. Novartis products are sold in approximately 155 countries around the world.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Vasant Narasimhan, M.D.
Consiglio di amministrazione
Harry Kirsch, Dr. Klaus Moosmayer, Dr. Steffen Lang, Karen L. Hale, Rob Kowalski, Shreeram Aradhye, Victor Bulto, Aharon (Ronny) Gal, Dr. Fiona H. Marshall, Patrick Horber
Consiglio di sorveglianza
Dr. Joerg Reinhardt, Bridgette Heller, Charles L. Sawyers, M.D., Dr. Charlotte Pamer-Wieser, Dr. Nancy C. Andrews, Elizabeth Doherty, Frans van Houten, Simon Moroney, Ton Buechner, William T. Winters, Daniel Hochstrasser, Ana de Pro Gonzalo, John D. Young, Patrice Bula
 

Dati aziendali

Name: Novartis AG
Indirizzo: Lichtstrasse 35,CH-4002 Basel
Telefono: +41-61-324-1111
Fax: +41-61-324-8001
E-mail: -
Internet: www.novartis.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 86.85%
Data dell'IPO: 07/03/1996

Rapporti con gli investitori

Name: Imke Kappes
IR telefono: +41 61 324 8269
IR Fax: -
IR e-mail: investor.relations@n...tis.com investor.relations@novartis.com

Company calendar

CW 5 | 31/01/2025 4th Quarter/Annual Report
CW 10 | 07/03/2025 General Shareholder Meeting
 

Principali azionisti

Altri
 
91.20%
Emasan AG, Basel
 
3.90%
UBS Fund Management (Switzerland) AG, Basel
 
2.70%
Credit Suisse Funds AG, Zurich
 
2.20%